Lung Irradiation for COVID-19 Pneumonia

Status Withdrawn

Clinical Trial Summary

In this research study the investigators want to learn more about the potential benefit of radiation to the lung to improve the health of patients who are hospitalized with Coronavirus-19 (COVID-19) due to infection with a virus called SARS-CoV-2. This infection causes inflammation of the lung, which can make it difficult to breathe. As a result, patients may need supplemental oxygen or be placed on a ventilator. The investigators believe that low dose radiation therapy to the lung may reduce this inflammation and increase the likelihood that patients will need less oxygen support such as ventilation or supplemental oxygen, or be discharged from the hospital in fewer days, compared to without radiation therapy. The amount of radiation is much lower than what is typically used to treat other conditions such as cancer, although it is higher than the dose used for routine medical imaging.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04393948
Study type	Interventional
Source	Brigham and Women's Hospital
Contact
Status	Withdrawn
Phase	N/A
Start date	June 19, 2020
Completion date	September 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04410510` - P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19	Phase 2/Phase 3
Withdrawn	`NCT04456426` - Characteristics of Patients With COVID-19 in Meta State, Colombia
Terminated	`NCT04435457` - Cardiovascular Implications of COVID-19
Withdrawn	`NCT04386447` - Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19	Phase 2
Suspended	`NCT04385771` - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation	N/A
Completed	`NCT04357834` - WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
Completed	`NCT04405934` - COG-UK Project Hospital-Onset COVID-19 Infections Study	N/A
Completed	`NCT04615936` - Nasal Photodisinfection COVID-19 Proof of Concept Study	N/A
Completed	`NCT04369794` - COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement	Phase 4
Terminated	`NCT04401410` - Anti-SARS Cov-2 T Cell Infusions for COVID 19	Phase 1
Completed	`NCT04542850` - Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19	N/A
Completed	`NCT04382040` - A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19	Phase 2
Completed	`NCT04378582` - Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU
Completed	`NCT04366908` - Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome	Phase 2
Completed	`NCT04383587` - Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers	N/A
Recruiting	`NCT04402814` - IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.
Completed	`NCT04374565` - Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia	Phase 2
Completed	`NCT04425889` - COVID-19 Antibodies Among Healthcare Workers
Completed	`NCT04395924` - Maternal-foetal Transmission of SARS-Cov-2
Not yet recruiting	`NCT04405492` - Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19	N/A